Document is current
Any future updates will be listed below
-
Authors
Okimoto, Nobukazu https://orcid.org/0000-0001-5323-0350
Sakai, Akinori
Yoshioka, Toru
Kobayashi, Tomohiro
Asano, Kei
Akahoshi, Shojiro
Ishikura, Toru
Fukuhara, Shito
Fuse, Yoshifumi
Mizuno, Toshiyuki
Katae, Yuji
Matsumoto, Hidehiro
Ogawa, Takayuki
Nishida, Shigeki
Ikeda, Satoshi
Menuki, Kunitaka
Saito, Jun
Okazaki, Yuichi
Mizuno, Naoyuki
Fujiwara, Saeko
- License Information
-
More Information
Article History
Received: 31 May 2019
Accepted: 13 September 2019
First Online: 4 October 2019
Compliance with ethical standards
:
: N Okimoto has received grants from Asahi-Kasei Pharmaceutical Co., Ltd., during the conduct of the study; personal fees from Asahi-Kasei Pharmaceutical Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Daiichi-Sankyo Co. Ltd., Eisai Co., Ltd., Mitsubishi-Tanabe Pharma Corp., Ono Pharmaceutical Co., Pfizer Japan Inc., Shionogi & Co., Ltd., Kaken Pharmaceutical Co. Ltd., Hisamitsu Pharmaceutical Co, Inc. and Teijin Pharma Ltd., outside the submitted work. A. Sakai has received grants from Asahi-Kasei Pharmaceutical Co., Ltd., during the conduct of the study; grants and personal fees from Asahi Kasei Pharma Corporation, Daiichi Sankyo Co., Ltd., and Chugai Pharmaceutical Co., Ltd., personal fees from Taisho Toyama Pharmaceutical Co., Ltd., outside the submitted work. S. Ikeda has received grants from Asahi-Kasei Pharmaceutical Co., Ltd., during the conduct of the study; Chugai Pharmaceutical Co., Daiichi-Sankyo Co., Ltd., Pfizer Japan Inc., Takeda Pharmaceutical Co. and Teijin Pharma Ltd., outside the submitted work. T. Yoshioka, T. Kobayashi, K. Asano, S. Akahoshi, T. Ishikura, S. Fukuhara, Y. Fuse, T. Mizuno, Y. Katae, H. Matsumoto, T. Ogawa, S. Nishida, K. Menuki, J. Saito, Y. Okazaki and N. Mizuno received grants from Asahi-Kasei Pharmaceutical Co., Ltd. S. Fujiwara declares she has no conflict of interest.
